Study of the efficacy and safety of vitamin D add-on standard treatment regimen for children with attention-deficit hyperactivity disorder in 7- to 14 year-Old : A 12 weeks randomized, open-label, parallel group Study

Mazandaran University of Medical Sciences0 个研究点目标入组 38 人开始时间: 待定最近更新: 2018年6月18日

适应症

试验速览

暂无简介。

•7-14 years old children diagnosed attention deficit hyperactivity disorder children by two psychiatrists and based on DSM-V
•Without vitamin D deficiency (Serum 25(OH) vitamin D levels above 30ng/ml)
•All patients are on standard treatment regimen for attention-deficit hyperactivity disorder for at least 3 months and a stable dose for at least 1 month

•Acute relapse
•Psychiatric comorbidity as defined by DSM-V
•Mental retardation
•Neurological diseases such as delirium, seizure, traumatic brain injury
•Current significant unstable medical illness
•Hypersensitivity to vitamin D
•Previous treatment with any products enriched with vitamin D at least 2 months before the initiation
•Unwillingness of the patient or his guardian to participate in the study

发起方